Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 210-043-9 | CAS number: 603-48-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- See additional information on materials and methods
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- See additional information on materials and methods
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- See additional information on materials and methods
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- N,N,N',N',N'',N''-hexamethyl-4,4',4''-methylidynetrianiline
- EC Number:
- 210-043-9
- EC Name:
- N,N,N',N',N'',N''-hexamethyl-4,4',4''-methylidynetrianiline
- Cas Number:
- 603-48-5
- Molecular formula:
- C25H31N3
- IUPAC Name:
- 4-{bis[4-(dimethylamino)phenyl]methyl}-N,N-dimethylaniline
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Purity: 99.4%
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA:J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo RMS Inc., Fredrick, MD
- Females (if applicable) nulliparous and non-pregnant: Yes
- Age at study initiation: Preliminary test: 10 weeks old and Main test: 9-11 weeks old
- Weight at study initiation: 18.0-22.8 g
- Housing: The animals were individually housed in plastic solid bottom cages during the dosing and resting phase of the study. After final weighing until sacrifice, animals were housed in their respective dose groups in plastic cages with bedding. Bedding in the plastic, solid bottom cages was changed at least once per week. Enrichment (e.g., nesting material) was placed in each cage.
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 7-21 days
- Indication of any skin lesions: No
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-28ºC
- Humidity (%): 45-63%
- Air changes (per hr): 12 or 13
- Photoperiod (hrs dark / hrs light): 12 hour light/dark cycle
Study design: in vivo (LLNA)
- Vehicle:
- other: 1% Pluronic® L92
- Concentration:
- 5, 10, and 25%
- No. of animals per dose:
- Preliminary irritation study: 2 per group
LLNA study: 5 per group - Details on study design:
- PRE-SCREEN TESTS:
- Compound solubility: The test substance, as received, was a solid. Solubility testing conducted by PSL indicated that the test substance was suspendable in 1% Pluronic® L92
- Irritation: No irritation at concentrations up to 25%
- Systemic toxicity: No signs of toxicity were observed
- Ear thickness measurements: Not examined
- Erythema scores: No irritation was observed
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response: Any test substance that produces an SI > 3 in the LLNA is normally considered “positive” for dermal sensitization potential
TREATMENT PREPARATION AND ADMINISTRATION: Concentrations of 5%, 10% and 25% were selected for the main test based on results of the preliminary screening test. Dilutions of the test substance were prepared as w/w mixtures in 1% Pluronic® L92. The vehicle control, 1% Pluronic® L92, and a single concentration of a 25% w/w mixture of HCA in 1% Pluronic® L92 were also prepared. All dosage preparations were freshly prepared on the day of application. Beginning on Day 1, a quantity of 25 µL of the appropriate test substance concentration, the positive control substance, or the vehicle alone was applied to the dorsum of both ears of each mouse once per day for three consecutive days (Days 1, 2, and 3) using a micropipette. During application, the material was gently spread as evenly as possible over the dorsal surface of the ear using the tip of the pipette. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Significance was judged at p < 0.05. The treated groups and negative vehicle control group were compared using a One-Way Analysis of Variance (ANOVA), followed by comparison of the treated groups to control by Dunnett’s t-test for multiple comparisons (INSTAT Biostatistics, Graph Pad Software, San Diego, CA). Outlier analysis was conducted using methods described in Grubbs (1969). Procedures for Detecting Outlying Observations in Samples. Technometrics, 11(1):1-21.
Results and discussion
- Positive control results:
- Very slight to well defined erythema (scores of 1 or 2) were evident at seven positive control sites on Day 2 and at all sites on Days 3 and 6. Slight oedema (score of 1) was present at three sites on Day 3 and nine sites Day 6. Desquamation was present at five sites on Day 3 and all sites on Day 6. The SI for the positive control was 6.04.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 1.15
- Test group / Remarks:
- 5% test substance
- Key result
- Parameter:
- SI
- Value:
- 0.96
- Test group / Remarks:
- 10% test substance
- Key result
- Parameter:
- SI
- Value:
- 1.45
- Test group / Remarks:
- 25% test substance
- Cellular proliferation data / Observations:
- No dermal irritation was observed for any of the vehicle or test substance group sites.
Any other information on results incl. tables
TABLE 1: INDIVIDUAL DPM[1]VALUES
Group |
Animal # |
dpm |
dpm minus background[2] |
Group mean dpm |
Std. Dev. |
SI[3] |
SI ≥ 3 |
Vehicle control |
3601 3602 3603 3604 3605 |
3974.42 2690.29 2069.04 2458.30 2776.09 |
3922.30 2638.17 2016.92 2406.18 2723.97 |
2741.51 |
714.62 |
----- |
----- |
Positive Control |
3606 3607 3608 3609 3610 |
16646.44 17782.60 13550.30 17385.71 17750.46 |
16594.32 17730.48 13498.18* 17333.59 17698.34 |
16570.98 |
1777.61 |
6.04 |
Yes |
5% TS |
3611 3612 3613 3614 3615 |
4759.20 4497.14 1457.88 3515.77 1801.68 |
4707.08 4445.02 1405.76 3463.65 1749.56 |
3154.21 |
1516.86 |
1.15 |
No |
10% TS |
3616 3617 3618 3619 3620 |
4228.21 1717.77 1140.26 3459.57 2887.66 |
4176.09 1665.65 1088.14 3407.45 2835.54 |
2634.57 |
1259.39 |
0.96 |
No |
25% TS |
3621 3622 3633 3634 3635 |
3953.37 4967.70 4547.26 2226.90 4389.58 |
3901.25 4915.58 4495.14 2174.78 4337.46 |
3964.84 |
1064.46 |
1.45 |
No |
*The dpm value for Animal No. 3608 was determined to be an outlier, but was included in the average and the standard deviation calculation for the test group. There is no indication in the raw data that this animal was dosed incorrectly; therefore, this animal will not be excluded from the calculations.
TABLE 2: STIMULATION INDEX
Group |
Group mean dpm |
SI |
Sensitization |
Vehicle control |
2741.51 |
----- |
Not applicable |
Positive control |
16570.98** |
6.04 |
Positive – valid study |
5% Test substance |
3154.21 |
1.15 |
Not a sensitizer |
10% Test substance |
2634.57 |
0.96 |
Not a sensitizer |
25% Test substance |
3964.84 |
1.45 |
Not a sensitizer |
** Statistically significant difference from vehicle control at p < 0.01 by Dunnett’s Multiple Comparisons Test
[1]Disintegrations per minute
[2]Values analysed for outliers, Grubbs 1969
[3]Stimulation Index = Average dpm of Test Substance/Average dpm of Vehicle
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance was not a skin sensitizer when tested in the LLNA.
- Executive summary:
A dermal sensitization test was conducted with mice to determine the potential for the test substance to produce sensitization after repeated topical applications (OECD Guideline 429, U.S. EPA Health Effects Test Guidelines, OPPTS 870.2600, and Official Journal of the European Communities. Methods for the Determination of Toxicity and Health Effects, Part B.42 (Skin Sensitization: Local Lymph Node Assay) Commission Regulation (EC) No. 440/2008).
Three concentrations of the test substance (5%, 10% and 25%) in 1% Pluronic® L92 Surfactant w/w in distilled water and the vehicle alone were topically applied to twenty healthy test mice (5 mice/group) for three consecutive days. Three days after the last application, the mice were given an IV injection containing 20 μCi of 3H-methyl thymidine. Approximately five hours later, all animals were euthanized via an overdose of inhaled Isoflurane and the draining (auricular) lymph nodes were harvested and prepared for analysis in a scintillation counter. The results are presented in disintegrations per minute per mouse (dpm/mouse). Each animal’s ears were also evaluated for erythema and oedema prior to each application and again on Day 6, prior to the IV injection. A positive control group (five animals) was maintained under the same environmental conditions and treated with a 25% w/w mixture of alpha-Hexylcinnamaldehyde, ≥ 95% (HCA) in 1% Pluronic® L92 in the same manner as the test animals.
Based on the results of this study, the test substance is not considered to be a contact dermal sensitizer at concentrations less than or equal to 25% in the LLNA. Proper conduct of the LLNA was confirmed via a positive response with 25% alpha-Hexyl-cinnamaldehyde, ≥ 95% (HCA), a moderate contact sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.